Stand out for this role — generate a tailored resume and cover letter in about a minute.
CSL Seqirus, a global leader in influenza vaccines, is seeking a Patient Engagement Lead in the Maidenhead area. The role focuses on embedding patient perspectives into protocol design, recruitment and site engagement, partnering with patient groups and advocacy organizations.
You will translate patient insights into actionable recommendations for study teams, influence external representation, and collaborate across global functions to improve trial experiences for patients and sites.
At CSL, we believe that patients are more than participants in clinical research. They are partners in the development of life-changing therapies. Our Patient Engagement team is dedicated to ensuring that the patient voice is embedded throughout the drug development journey, helping us design clinical programs that are more meaningful, accessible, and responsive to the needs of those we serve. As a Patient Engagement Lead, you will have the unique opportunity to influence the future of clinical development by bringing patient perspectives directly into decision-making. Working across global, cross-functional teams, you will gather and translate patient insights into actionable recommendations that shape clinical development plans, protocol design, and participant experiences. You will partner closely with patient organizations, advocacy groups, patients, caregivers, and internal stakeholders to conduct advisory boards and other engagement activities that inform study design and patient-facing materials. Your work will help ensure that clinical trials are designed with patients, not just for patients. Hybrid based (3 days a week office) in Maidenhead (UK) What You'll Be Responsible For You will act as an advisor to study teams, turning insight from patients, caregivers, advocacy groups and sites into practical decisions on protocol design, recruitment and retention. You will also represent CSL externally and use data to show what is working and what needs to change.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.